TANFAC Industries Appoints Two New Directors

CHEMICALS
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
TANFAC Industries Appoints Two New Directors
Overview

TANFAC Industries Ltd. has appointed Dr. L. Ravichandran as an Additional and Whole-time Director for two years, and Dr. Ajay Kumar Singh as a Non-executive, Independent Director for five years. These key roles aim to bolster the company's leadership and corporate governance, pending shareholder approval.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

TANFAC Industries Ltd. has appointed two new directors to its board, enhancing its leadership and corporate governance. Dr. L. Ravichandran joins as an Additional and Whole-time Director for a two-year term, and Dr. Ajay Kumar Singh steps in as a Non-executive, Independent Director for five years. These appointments are pending shareholder approval.

The company's Board of Directors approved these key roles during a meeting on May 06, 2026. Dr. Ravichandran's appointment is effective from May 06, 2026, to May 05, 2028. Dr. Singh's tenure as a Non-executive, Independent Director will run from May 06, 2026, to May 05, 2031.

These appointments are seen as a strategic move to reinforce the company's leadership team and improve its board's composition. The addition of an independent director, in particular, is crucial for strengthening corporate governance and oversight.

TANFAC Industries, a manufacturer of hydrofluoric acid and derivatives, has seen board changes in recent years, notably following Anupam Rasayan India Limited's acquisition of a majority stake and joint control in March 2022. This ownership shift often prompts adjustments in board composition to align with new strategic directions. Previous appointments include Dr. R. K. Tyagi and Mr. Amreek Singh Sandhu as Independent Directors in March 2025 for five-year terms, and Afzal Harunbhai Malkani became Managing Director in January 2026. Director appointments typically follow recommendations from the Nomination and Remuneration Committee and require shareholder ratification.

A key factor for the finalization of these appointments is shareholder approval. Any dissent from shareholders could potentially delay or prevent their ratification.

Operating in the competitive chemicals sector, TANFAC Industries faces rivals such as SRF Ltd., Deepak Nitrite Ltd., and Navin Fluorine Inter., which also focus on specialty chemicals and fluorochemicals. In this market, robust board composition and strong governance practices are critical differentiators for attracting and retaining investor confidence.

Moving forward, investors will be watching the outcome of the shareholder approval process and observing how the new directors contribute to TANFAC's strategic initiatives and governance.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.